Levodopa Concentration Profile After Repeated Doses of Different Stalevo Strengths With 3.5 Hours Dosing Frequency; an Open, Randomised, Crossover, Levodopa/Carbidopa Controlled Single Centre Study in Healthy Subjects, Two Parallel Groups.
Phase of Trial: Phase I
Latest Information Update: 17 Sep 2011
At a glance
- Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
- Indications Dystonia; Parkinson's disease
- Focus Pharmacokinetics
- Acronyms NEWSTA
- Sponsors Orion
- 12 Aug 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 12 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Feb 2010 New trial record